Neuroprotection in Alzheimer's Disease
Editat de Illana Gozesen Limba Engleză Hardback – 16 ian 2017
This book brings together the latest findings, both basic, and clinical, under the same cover, making it easy for the reader to obtain a complete overview of the state-of-the-field and beyond. Alzheimer's disease is the most common form of dementia, accounting for 60 to 80 percent of dementia cases. It is a progressive brain disease that slowly destroys memory, thinking skills, and eventually, even the ability to carry out the simplest tasks. It is characterized by death of synapses coupled to death nerve cells and brain degeneration which is manifested by loss of cognitive abilities. Understanding neuroprotection in Alzheimer’s disease will pave the path to better disease management and novel therapeutics.
- Comprehensive reference detailing neuroprotection in Alzheimer’s Disease, with details on nerve cell protection and new advances in disease management
- Combines the knowledge and points-of-view of both medical doctors and basic scientists, putting the subject at the forefront for further clinical development
- Edited by one of the leading researchers in Alzheimer’s Disease
Preț: 612.64 lei
Preț vechi: 860.60 lei
-29% Nou
Puncte Express: 919
Preț estimativ în valută:
117.26€ • 122.21$ • 97.61£
117.26€ • 122.21$ • 97.61£
Carte tipărită la comandă
Livrare economică 30 decembrie 24 - 13 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128036907
ISBN-10: 0128036907
Pagini: 342
Dimensiuni: 152 x 229 x 2 mm
Greutate: 0.63 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128036907
Pagini: 342
Dimensiuni: 152 x 229 x 2 mm
Greutate: 0.63 kg
Editura: ELSEVIER SCIENCE
Cuprins
1. Introduction
2. Neural regeneration as a disease modifying therapeutic strategy for Alzheimer's disease
3. Animal models
4. Mechanisms of Neuronal Microtubule Loss in Alzheimer’s Disease
5. Tau-centric therapies for treating Alzheimer’s Disease
6. The potential of small molecules in preventing tau oligomers formation and toxicity
7. A novel neuroprotection target with distinct regulation in stroke and Alzheimer´s disease
8. Sirtuin modulation as novel neuroprotective strategy for Alzheimer's Disease
9. Rescue of neurons by resolving inflammation
10. Targeting transition metals for neuroprotection in Alzheimer’s disease
11. Multifunctional effect of human serum albumin towards neuroprotection in Alzheimer disease
12. RGS2 and SIRT1 link renin angiotensin aldosterone system to Alzheimer’s disease
13. Neuroprotective drug development: the story of ADNP, NAP (davunetide) and SKIP
2. Neural regeneration as a disease modifying therapeutic strategy for Alzheimer's disease
3. Animal models
4. Mechanisms of Neuronal Microtubule Loss in Alzheimer’s Disease
5. Tau-centric therapies for treating Alzheimer’s Disease
6. The potential of small molecules in preventing tau oligomers formation and toxicity
7. A novel neuroprotection target with distinct regulation in stroke and Alzheimer´s disease
8. Sirtuin modulation as novel neuroprotective strategy for Alzheimer's Disease
9. Rescue of neurons by resolving inflammation
10. Targeting transition metals for neuroprotection in Alzheimer’s disease
11. Multifunctional effect of human serum albumin towards neuroprotection in Alzheimer disease
12. RGS2 and SIRT1 link renin angiotensin aldosterone system to Alzheimer’s disease
13. Neuroprotective drug development: the story of ADNP, NAP (davunetide) and SKIP